Eclectic Remedy LLC – Trademark Portfolio
Entity Type: 16
Eclectic Remedy LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include PILLNO, ER BLENDESSE, and ECHT REMEDIES ER. The owner is based in New York, NY.
165 William Street, 4th Floor
New York, NY 10038
Showing of trademarks Trademarks
Trademark Classifications
Eclectic Remedy LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Eclectic Remedy LLC have?
Eclectic Remedy LLC has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned.
What trademark classes does Eclectic Remedy LLC file in?
Eclectic Remedy LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 41 (Education & Entertainment). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Eclectic Remedy LLC's most well-known trademarks?
Eclectic Remedy LLC's registered trademark portfolio includes well-known marks such as PILLNO, ER BLENDESSE, and ECHT REMEDIES ER. These are among 3 currently registered trademarks in the portfolio.
What is Eclectic Remedy LLC's trademark registration success rate?
Eclectic Remedy LLC has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.